PRECISION MEDICINE WEBINARS
FOR HEALTH PLANS
Precision Medicine is Exploding - How Will Your Health Plan Scale to Keep Up?
Dr. Lee Newcomer, oncologist and former UnitedHealth executive, along with Clynt Taylor, CEO of Trapelo Health, host this AHIP-sponsored webinar to help health plan leaders understand the explosion in precision medicine and develop a strategy for managing the growing cost and complexity.
In this 60-minute webinar you'll learn about:
-
the enormous cost exposure that oncology patients present for health plans that don’t have precision medicine programs in place;
-
why traditional prior authorization processes can’t scale; and
-
a first-of-its-kind solution that enables payers and physicians to align in real time to make evidence-based decisions and ensure patients receive the most appropriate care without delay.
About the Presenters
Lee Newcomer, MD, MHA, Oncologist and Principal, Lee N. Newcomer Consulting
Dr. Newcomer has dedicated his career to creating new approaches to make cancer care more effective and affordable, and to create novel approaches for improved care of cancer patients. The majority of his career was spent with UnitedHealth Group as Chief Medical Officer where he built the company’s medical management programs and later helped create the first commercial cancer database combining clinical and claims data. Prior to his work at UnitedHealth Group, Dr. Newcomer practiced medical oncology for nine years.
Clynt Taylor, CEO, Trapelo Health
Clynt Taylor is the Chief Executive Officer of Trapelo Health and a member of the company’s board of directors. He brings more than 20 years of experience in healthcare technology. Under his leadership, Trapelo Health launched the first precision medicine platform used by oncologists, labs, payers, and pharma, and founded the Precision Medicine Podcast, a media platform that brings together industry leaders to help accelerate the effective use of precision medicine.
Hear more on the Precision Medicine Podcast:
Episode #11 with Clynt Taylor: How Collaboration Can Ease the Burdens of Prior Authorization in Precision Medicine Today
How can we resolve the complexities of using precision medicine for cancer care?
Trapelo knows.
